Development Level

Tbio 4 | 11,651
Tchem 4 | 1,388

IMPC Phenotype

decreased circulating HDL chol... 1 | 68
decreased circulating insulin ... 1 | 76
decreased lean body mass 1 | 135
decreased total body fat amoun... 1 | 207
embryonic lethality prior to o... 1 | 239
embryonic lethality prior to t... 1 | 278
increased circulating HDL chol... 1 | 80
increased circulating choleste... 1 | 66
increased lean body mass 1 | 172
increased total body fat amoun... 1 | 134
preweaning lethality, complete... 1 | 979

Disease

Cancer 5 | 2,499
Carcinoma 5 | 11,493
ovarian cancer 5 | 8,520
osteosarcoma 4 | 7,950
psoriasis 4 | 6,694
Myocardial Infarction 3 | 151
Nerve Degeneration 3 | 121
medulloblastoma, large-cell 3 | 6,241
Alzheimer's disease 2 | 658
Breast cancer 2 | 3,578
Colonic Neoplasms 2 | 142
Obesity 2 | 678
Prostatic Neoplasms 2 | 495
Vascular disease 2 | 319
adrenocortical carcinoma 2 | 1,428
cystic fibrosis 2 | 1,696
diabetes mellitus 2 | 1,728
glioblastoma 2 | 5,792
group 3 medulloblastoma 2 | 4,104
invasive ductal carcinoma 2 | 2,951
lung adenocarcinoma 2 | 2,716
spina bifida 2 | 1,074
tuberculosis 2 | 2,010
Absent reflex 1 | 92
Absent tendon reflex 1 | 92
Acute kidney injury 1 | 70
Alzheimer Disease 1 | 83
Amyotrophic lateral sclerosis 1 | 451
Amyotrophic lateral sclerosis type 8 1 | 10
Anxiety 1 | 136
Anxiety disease 1 | 113
Aortic aneurysm 1 | 38
B-Cell Lymphomas 1 | 12
Bipolar I disorder 1 | 23
Breast Neoplasms 1 | 445
Carcinoma of colon 1 | 32
Cerebral Hemorrhage 1 | 42
Chemical and Drug Induced Liver Injury 1 | 195
Decreased tendon reflex 1 | 122
Diabetes Mellitus, Experimental 1 | 108
Diabetes Mellitus, Noninsulin-Dependent 1 | 31
Diphtheria 1 | 40
Disease of anatomical entity 1 | 32
Dysarthria 1 | 192
Dyspnea 1 | 76
EMG: neuropathic changes 1 | 15
Esophageal Neoplasms 1 | 69
Esophageal Squamous Cell Carcinoma 1 | 77
Fatigue 1 | 182
Fatty liver disease 1 | 103
Generalized muscle weakness 1 | 57
HIV Infections 1 | 102
Hyperglycemia 1 | 137
Hyperinsulinism 1 | 133
Inflammation 1 | 120
Insulin Resistance 1 | 72
Intestinal Neoplasms 1 | 12
Ischemia 1 | 28
Liver Cirrhosis, Experimental 1 | 769
Liver Neoplasms, Experimental 1 | 59
Liver disease 1 | 237
Lymphoid leukemia 1 | 160
Lymphoma 1 | 81
Lymphoma, B-Cell 1 | 6
Lymphoma, T-Cell, Cutaneous 1 | 22
Mammary Neoplasms 1 | 425
Mediastinal Neoplasms 1 | 2
Microsatellite Instability 1 | 12
Mood swings 1 | 77
Morphological abnormality of the pyramidal tract 1 | 12
Muscle Cramp 1 | 55
Muscle Spasticity 1 | 195
Muscle weakness, progressive 1 | 22
Muscular atrophy 1 | 71
Muscular fasciculation 1 | 22
Myocardial Reperfusion Injury 1 | 37
Neuro-degenerative disease 1 | 43
Neurodegenerative Disorders 1 | 79
Neurogenic Muscular Atrophy 1 | 139
Neurogenic muscle atrophy, especially in the lower limbs 1 | 139
Neuronal loss 1 | 25
Pain 1 | 103
Paralysed 1 | 42
Pneumonia 1 | 174
Proximal muscle weakness 1 | 47
Proximal neurogenic muscle weakness 1 | 47
Pulmonary embolism 1 | 55
Pyramidal tract disease 1 | 12
Reflex, Deep Tendon, Absent 1 | 92
Respiratory Failure 1 | 104
Respiratory Hypersensitivity 1 | 19
Skeletal muscle atrophy 1 | 139
Spinal muscular atrophy 1 | 34
Spinocerebellar ataxia type 17 1 | 7
Squamous cell carcinoma of esophagus 1 | 77
Static Tremor 1 | 21
Telangiectasis 1 | 36
Testicular cancer 1 | 25
X-linked cerebral adrenoleukodystrophy 1 | 116
muscle degeneration 1 | 139

Tissue

Blood and immune system 8 | 16,909
Cardiovascular System 8 | 15,192
Digestive Tract 8 | 17,369
Endocrine System 8 | 18,159
Female tissues 8 | 17,400
Liver and Pancreas 8 | 16,750
Male tissues 8 | 17,142
Nervous System 8 | 16,725
Respiratory system 8 | 16,393
Skin and soft tissues 8 | 17,230
Urinary Tract 8 | 16,678

Target Family

Non-IDG 5 | 12,091
Enzyme 2 | 4,145
Kinase 1 | 634

GO Process

activation of signaling protei... 8 | 8
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
78 kDa glucose-regulated protein HSPA5 Tchem Non-IDG -3.35010 2184.4 1074
Apoptosis regulator BAX BAX Tchem Non-IDG -2.57834 248.4 1395
Serine/threonine-protein kinase/endoribonuclease IRE1 ERN1 Tchem Kinase -2.44644 224.3 489
Disabled homolog 2-interacting protein DAB2IP Tbio Non-IDG -1.69193 60.3 59
Bcl-2 homologous antagonist/killer BAK1 Tbio Non-IDG -2.29199 175.9 554
Vesicle-associated membrane protein-associated protein B/C VAPB Tbio Non-IDG -2.21349 169.4 239
Tyrosine-protein phosphatase non-receptor type 1 PTPN1 Tchem Enzyme -3.07650 1308.1 528
Mono [ADP-ribose] polymerase PARP16 PARP16 Tbio Enzyme -0.48667 3.37 134